PNC Financial Services Group
GPCR icon

PNC Financial Services Group’s Structure Therapeutics GPCR Stock Holding History

PNC Financial Services Group’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.06K Sell
34
-2,748
-99% -$129K ﹤0.01% 4982
2026
Q2 		$149K Sell
2,782
-72
-3% -$3.18K ﹤0.01% 2668
2026
Q1 		$138K Sell
2,854
-1,072
-27% -$73.4K ﹤0.01% 2593
2025
Q4 		$273K Sell
3,926
-902
-19% -$36.8K ﹤0.01% 2072
2025
Q3 		$135K Buy
4,828
+413
+9% +$8.23K ﹤0.01% 2594
2025
Q2 		$91.6K Buy
4,415
+994
+29% +$21.9K ﹤0.01% 2765
2025
Q1 		$59.2K Buy
3,421
+144
+4% +$3.53K ﹤0.01% 2994
2024
Q4 		$88.9K Sell
3,277
-42
-1% -$1.49K ﹤0.01% 2752
2024
Q3 		$146K Buy
3,319
+7
+0.2% +$271 ﹤0.01% 2435
2024
Q2 		$130K Buy
3,312
+3,253
+5,514% +$134K ﹤0.01% 2445
2024
Q1 		$2.53K Buy
59
+9
+18% +$380 ﹤0.01% 4141
2023
Q4 		$2.04K Buy
+50
New +$2.86K ﹤0.01% 4185

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Capitolis Liquid Global Markets
Capitolis Liquid Global Markets New York $22.4B AUM 40.52% 1-Year Est. Return
Pacific Heights Asset Management
Pacific Heights Asset Management San Francisco, California $3.1B AUM 37.54% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

PNC Financial Services Group's GPCR Position: Q3 2026 in Review

PNC Financial Services Group reduced its Structure Therapeutics (GPCR) stake by 99% in Q3 2026, selling an estimated $129K and leaving 34 shares worth $1.06K. The position accounts for ﹤0.01% of the portfolio, ranked #4982.

PNC Financial Services Group first reported a position in GPCR in Q4 2023 and has held it in 12 quarters since. The position peaked at $273K in Q4 2025. 113 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.

  • PNC Financial Services Group held 34 shares of Structure Therapeutics worth $1.06K as of Q3 2026.
  • PNC Financial Services Group sold 2,748 Structure Therapeutics shares in Q3 2026, an estimated $129K.
  • Structure Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4982 holding.
  • PNC Financial Services Group first reported a position in Structure Therapeutics in Q4 2023 and has held it in 12 quarters since.
  • PNC Financial Services Group's Structure Therapeutics position peaked at $273K in Q4 2025.
  • 113 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.